On January 20, 2013, NuPathe Inc of Coshohocken, PA, announced that the U.S. Food and Drug Administration (FDA) approved the Zecuity patch for the treatment of acute migraine in adult patients, with or without aura (changes in vision including blind spots, zigzag patterns, seeing flashing light and/or things that are not there, for example). Migraine [...]

December 21, 2012 – Mylan Inc. announced today that its Mylan Institutional business is conducting a voluntary nationwide recall to the retail level of three lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg (Lots 3037841, 3040859 and 3042573).  The three lots were manufactured by Qualitest Pharmaceuticals, and Mylan Institutional repackaged and distributed [...]

December 6, 2012 - Qualitest, a subsidiary of Endo Health Solutions, (Nasdaq: ENDP) today issued a voluntary nationwide recall for 101 lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg. This includes product with the following NDC numbers and lot numbers beginning with the letter “C”. For detailed information, please click the following link:  [...]

November 28, 2012 - On Nov. 9, 2012, Ranbaxy Pharmaceuticals informed its customers of a voluntary recall of certain lots of the company’s 10mg, 20mg, and 40mg dosage strengths of atorvastatin tablets.  The lots of atorvastatin, packaged in bottles of 90 and 500 tablets, are being recalled due to possible contamination with very small glass particles [...]

Greenstone LLC, of Peapack, NJ, has announced that on November 1, 2012, it began shipping its generic version of the drug Arthrotec (diclofenac sodium with misoprostol tablets), indicated for the treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their [...]